Your browser doesn't support javascript.
loading
Diagnostic and therapeutic approach of central sleep apnea in heart failure - the role of adaptive servo-ventilation. A statement of the Portuguese society of pulmonology and the Portuguese sleep association.
Correia, S; Sousa, S; Drummond, M; Pinto, P; Staats, R; Brito, D; Lousada, N; Cardoso, J S; Moita, J.
Afiliación
  • Correia S; Hospital Pedro Hispano, Porto, Portugal. Electronic address: silviapaiscorreia@gmail.com.
  • Sousa S; Centro Hospitalar de Setubal, Portugal.
  • Drummond M; Centro Hospitalar Universitario do Porto, Porto, Portugal.
  • Pinto P; Centro Hospitalar Universitario Lisboa Norte, Lisboa, Portugal.
  • Staats R; Centro Hospitalar Universitario Lisboa Norte, Lisboa, Portugal.
  • Brito D; Centro Hospitalar Universitario Lisboa Norte, Lisboa, Portugal.
  • Lousada N; Centro Hospitalar Universitario Lisboa Norte, Lisboa, Portugal.
  • Cardoso JS; Centro Hospitalar Universitário de São João, Portugal.
  • Moita J; Centro Hospitalar e Universitario de Coimbra, Portugal.
Pulmonology ; 29(2): 138-143, 2023.
Article en En | MEDLINE | ID: mdl-35501278
It is known that patients with heart failure (HF) have an increased risk of developing central sleep apnoea (CSA), with Cheyne-Stokes respiration. The development of servo-ventilation aimed to treat CSA and improve the quality of life (QoL) of these patients. A large randomized clinical study, SERVE-HF, was conducted in order to test this theory in patients with HF and reduced ejection fraction (HFrEF). The results from this trial seemed to indicate that, in these patients, there was no beneficial effect of the assisted ventilation in CSA treatment. More surprisingly, an increased rate of all-cause or cardiovascular mortality was observed. This has led to dramatic changes in clinical practice, with decreased frequency of servo-ventilation prescription across Europe, including Portugal, due to changes in the guidelines. However, SERVE-HF was conducted only in severe systolic HF patients with CSA, and caution must be taken when extrapolating these results to HF patients with preserved ejection fraction or CSA patients without HF. The study also showed poor adherence, methodological and statistical gaps, including study design, patient selection, data collection and analysis, treatment adherence, and group crossovers, which have not been discussed in the trial as potential confounding factors and raise several concerns. Moreover, the adaptive servo-ventilation (ASV) device used in SERVE-HF was unable to lower the minimum support pressure below 3 mm H20, and this has been suggested as one of the probable contributing reasons to the excess mortality observed in this study. This limitation has since been solved, and this ASV device is no longer used. This paper describes the results of a Portuguese Task Force on the treatment of central sleep apnoea in patients with chronic HF.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumología / Apnea Central del Sueño / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Risk_factors_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Pulmonology Año: 2023 Tipo del documento: Article Pais de publicación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumología / Apnea Central del Sueño / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Risk_factors_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Pulmonology Año: 2023 Tipo del documento: Article Pais de publicación: España